Covetrus reports 11% sales growth in Q3 results

Covetrus Inc. (Nasdaq: CVET), the Portland-based animal-health company, reported sales were up 11% during the third quarter compared to the same period last year, driven by customer demand that reached pre-pandemic levels in some markets.

Net sales from July to September were $1.13 billion, about $80 million more than analysts’ consensus expectations, and an increase from $1.02 billion for Q3 in 2019. The jump reflected “companion animal end-market growth that returned to pre-COVID-19 levels across many of the company’s major geographies” among other factors, Covetrus said in a news release late Tuesday. Read more

Related Posts

Maine’s life sciences sector growth could outpace other industries

Maine’s $2.3 billion life sciences sector, which employed close to 10,000 people in 2024, will outpace the growth of many other...

13 January 2025

IDEXX gets wiggle room to buy back more shares

IDEXX Laboratories Inc. (Nasdaq: IDXX), a Westbrook-based maker of veterinary diagnostics and software, has the green light from its board of...

10 December 2024

Maine’s first accredited lab for PFAS testing is expanding to meet demand

NORRIDGEWOCK, Maine — This week, the Biden administration moved to prevent dangerous “forever chemicals” from being released onto the market after a less...

6 December 2024